A Clinical Study of MK-1084 with Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

Trial Identifier: 3475-01F
Sponsor: MSD
Collaborator:
Daiichi Sankyo, Inc.
Start Date: April 2026
Primary Completion Date: August 2031
Study Completion Date: May 2037
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary - English

Trial Locations

Country Location
Brazil, Sao Paulo Barretos, Sao Paulo, Brazil, 14784-400
Brazil, Sao Paulo Sao Jose do Rio Preto, Sao Paulo, Brazil, 15090-000
Brazil, Sao Paulo São Paulo, Sao Paulo, Brazil, 01321001
Chile, Region M. de Santiago Santiago, Region M. de Santiago, Chile, 7500653
Chile, Region M. de Santiago Santiago, Region M. de Santiago, Chile, 7500921
Chile, Region M. de Santiago Santiago., Region M. de Santiago, Chile, 8420383
China, Guangdong Guangzhou, Guangdong, China, 510120
Greece, Attiki Athens, Attiki, Greece, 115 27
Greece, Attiki Athens, Attiki, Greece, 115 28
Hong Kong, N/A Hong Kong, N/A, Hong Kong, 000000
Israel, N/A Jerusalem, N/A, Israel, 9103102
Israel, N/A Ramat Gan, N/A, Israel, 5265601
Korea, Republic of, Seoul Seoul, Korea, Republic of, 03722
Spain, Barcelona Barcelona, Spain, 08036
Spain, Barcelona Hospitalet, Barcelona, Spain, 08908
Spain, Sevilla Sevilla, Spain, 41009
United States, FL Clermont, FL, United States, 34711
United States, IL Chicago, IL, United States, 60612